Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reetakshi Arora

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Vaccines|September 23, 2022
Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of MethamphetamineColin N Haile, Kurt J Varner, Xia Huijing, et al.
AIDS Research and Human Retroviruses|September 23, 2006
A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGNSeung-Jae Lee, Reetakshi Arora, Lara M Bull, et al.
The American Journal on Addictions|February 1, 2019
Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvantReetakshi Arora, Colin N Haile, Therese A Kosten, et al.
Journal of Virology|February 4, 2011
Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1Rajesh Thippeshappa, Patricia Polacino, Monica T Yu Kimata, et al.
The American Journal on Addictions|November 20, 2015
Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccineColin N Haile, Therese A Kosten, Xiaoyun Y Shen, et al.
Blood Advances|April 8, 2025
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucelSatabdi Saha, Lubna Rehman, Abdur Rehman, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
The Journal of Experimental Medicine|November 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltrationYifan Zhou, Yusra B Medik, Bhakti Patel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Vaccines|September 23, 2022
Active and Passive Immunization with an Anti-Methamphetamine Vaccine Attenuates the Behavioral and Cardiovascular Effects of MethamphetamineColin N Haile, Kurt J Varner, Xia Huijing, et al.
AIDS Research and Human Retroviruses|September 23, 2006
A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGNSeung-Jae Lee, Reetakshi Arora, Lara M Bull, et al.
The American Journal on Addictions|February 1, 2019
Preclinical efficacy of an anti-methamphetamine vaccine using E6020 adjuvantReetakshi Arora, Colin N Haile, Therese A Kosten, et al.
Journal of Virology|February 4, 2011
Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1Rajesh Thippeshappa, Patricia Polacino, Monica T Yu Kimata, et al.
The American Journal on Addictions|November 20, 2015
Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccineColin N Haile, Therese A Kosten, Xiaoyun Y Shen, et al.
Blood Advances|April 8, 2025
Longitudinal analysis of gut microbiome and metabolome correlates of response and toxicity with idecabtagene vicleucelSatabdi Saha, Lubna Rehman, Abdur Rehman, et al.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Nature|March 18, 2021
Identification of bacteria-derived HLA-bound peptides in melanomaShelly Kalaora, Adi Nagler, Deborah Nejman, et al.
The Journal of Experimental Medicine|November 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltrationYifan Zhou, Yusra B Medik, Bhakti Patel, et al.
Pageof 3